Trial intelligence / Profile preview

Naproxen vs meloxicam after fully impacted mandibular third molar surgery

IRCT20220418054585N1Phase 3Completed

Sponsor
Shahrekord University of Medical Sciences
Start
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in postoperative pain comparing Naproxen arm with Meloxicam arm (2 arms). Started May 2022; status: completed.

02

Drugs

naproxenmeloxicam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20220418054585N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220418054585N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call